Immediate Impact
37 standout
Citing Papers
Liquid biopsy in cancer: current status, challenges and future prospects
2024 Standout
The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors
2024 Standout
Works of Jo Raskin being referenced
INSIGHT 2: a Phase II Study of Tepotinib Plus Osimertinib in MET -Amplified NSCLC and First-Line Osimertinib Resistance
2021
Prognostic and Predictive Biomarkers in Non-Small Cell Lung Cancer Patients on Immunotherapy—The Role of Liquid Biopsy in Unraveling the Puzzle
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Jo Raskin | 230 | 172 | 10 | 108 | 37 | 370 | |
| Naohiro Nose | 275 | 216 | 2 | 115 | 23 | 396 | |
| Marco Brugia | 122 | 208 | 16 | 113 | 30 | 334 | |
| Hideko Isozaki | 194 | 201 | 9 | 203 | 30 | 364 | |
| Erica Quaquarini | 148 | 219 | 9 | 78 | 32 | 357 | |
| Xun Shi | 246 | 229 | 4 | 70 | 26 | 350 | |
| Paloma Martín-Martorell | 180 | 273 | 78 | 27 | 410 | ||
| Michèle Natale | 255 | 290 | 4 | 86 | 25 | 410 | |
| D.C. Doval | 228 | 99 | 7 | 72 | 37 | 337 | |
| Umberto Conte | 150 | 142 | 1 | 101 | 25 | 333 | |
| Estelamari Rodríguez | 149 | 181 | 6 | 116 | 48 | 344 |
All Works
Login with ORCID to disown or claim papers
Loading papers...